Nadav Friedmann
Net Worth

Last updated:

What is Nadav Friedmann net worth?

The estimated net worth of Dr. Nadav Friedmann is at least $7,470,309 as of 3 Oct 2022. He owns shares worth $570,309 as insider and has received compensation worth at least $6,900,000 in Cassava Sciences, Inc..

What is the salary of Nadav Friedmann?

Dr. Nadav Friedmann salary is $345,000 per year as Chief Medical Officer & Director in Cassava Sciences, Inc..

How old is Nadav Friedmann?

Dr. Nadav Friedmann is 82 years old, born in 1943.

What stocks does Nadav Friedmann currently own?

As insider, Dr. Nadav Friedmann owns shares in one company:

Company Title Shares Price per share Total value
Cassava Sciences, Inc. (SAVA) Chief Medical Officer & Director 259,255 $2.2 $570,309

What does Cassava Sciences, Inc. do?

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.

Nadav Friedmann insider trading

Cassava Sciences, Inc.

Dr. Nadav Friedmann has made 16 insider trades between 2005-2022, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 1,250,168 units of SAVA stock on 5 Jul 2011. As of 3 Oct 2022 he still owns at least 259,255 units of SAVA stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 9,376 $0.95 $8,907
Option
Common Stock 9,376 $0.95 $8,907
Option
Common Stock 3,501 $23.38 $81,853
Option
Common Stock 24,513 $23.38 $573,114
Option
Common Stock 24,513 $23.38 $573,114
Option
Common Stock 28,015 $53.55 $1,500,203
Option
Common Stock 28,015 $53.55 $1,500,203
Option
Common Stock 135,334 N/A N/A
Option
Common Stock 270,668 N/A N/A
Option
Common Stock 244,108 N/A N/A
Option
Common Stock 122,054 N/A N/A
Sale
Common Stock (1) 25,000 N/A N/A
Sale
Common Stock (3) 7,000 N/A N/A
Sale
Common Stock (2) 8,000 N/A N/A
Sale
Common Stock (1) 10,000 N/A N/A
Sale
Common Stock (1) 25,000 N/A N/A
Option
Common Stock 625,084 N/A N/A
Option
Common Stock 1,250,168 N/A N/A
Option
Common Stock 200,000 N/A N/A
Option
Common Stock 400,000 N/A N/A
Option
Common Stock 425,084 N/A N/A
Option
Common Stock 850,168 N/A N/A
Option
Common Stock 96,790 N/A N/A
Option
Common Stock 193,580 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Purchase
Common Stock 15,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Purchase
Common Stock 3,374 N/A N/A
Purchase
Common Stock 25,000 N/A N/A
Purchase
Common Stock 3,267 N/A N/A
Purchase
Common Stock 193 N/A N/A
Purchase
Common Stock 4,516 N/A N/A
Sale
Common Stock 4,000 N/A N/A
Sale
Common Stock 4,000 N/A N/A
Sale
Common Stock 4,000 N/A N/A
Sale
Common Stock 4,000 N/A N/A
Purchase
Common Stock 1,321 N/A N/A
Sale
Common Stock 4,000 N/A N/A
Sale
Common Stock 4,000 N/A N/A
Sale
Common Stock 4,000 N/A N/A
Purchase
Common Stock 4,154 N/A N/A
Sale
Common Stock 25,000 N/A N/A
Purchase
Common Stock 4,121 N/A N/A
Purchase
Common Stock 25,000 N/A N/A
Purchase
Common Stock 15,000 N/A N/A
Purchase
Common Stock 10,000 N/A N/A

Cassava Sciences key executives

Cassava Sciences, Inc. executives and other stock owners filed with the SEC: